Brief: I'rom Group unit ID Pharma to grant technology license to KOHJIN BIO
July 12 (Reuters) - I'rom Group Co Ltd 2372.T :
* Says unit ID Pharma to grant non-exclusive rights in Japan
regarding technology license for cancer treatment by amplifing
dendritic cells, to Japan-based co KOHJIN BIO
Source text in Japanese: https://goo.gl/0gL9dB
Further company Coverage: 2372.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))
Recent news on I'rom Co
See all newsTo Retire Treasury Shares Worth 1.89% Of Outstanding Stock On May 13
9-MTH group results
Blackstone-Backed Group To Launch Management Buyout Tender Offer For Its Shares On Feb 3 After Clearing Regulatory Process In Australia
Brief: ACCC Says Blackstone Acquisition Of Clinical Trial Service Provider Not Opposed
Brief: Australia's ACCC Says Blackstone's Proposed Acquisition Of I'Rom Raises Concerns